Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations might be linked to severe acne in women but not in men.

Females have higher estrogen receptor levels in hair than males, and these levels decrease in white hair compared to black hair.

Vitamin D3 and its receptor are important for hair growth, and understanding receptors could help treat hair graying and skin cancer.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Older men with lower levels of available testosterone are more likely to be frail.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

We need better ways to test and understand SARMs to make safer and more effective treatments.

MC4R gene variants not linked to female hair loss.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

Hair follicles produce and respond to melatonin, affecting hair growth and sensitivity to estrogen.

Lowering testosterone speeds up wound healing in male mice.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.